An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals
Over the last two years, global regulatory authorities have raised safety concerns on nitrosamine contamination in several drug classes, including angiotensin II receptor antagonists, histamine-2 receptor antagonists, antimicrobial agents, and antidiabetic drugs. To avoid carcinogenic and mutagenic...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2023-02-01
|
| Seri Bilgileri: | Saudi Pharmaceutical Journal |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1319016422003097 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|